Plain-English translation of NCT06654375 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing endovascular thrombectomy—a minimally invasive procedure that removes blood clots from major vessels in the brain—in stroke patients who arrive at the hospital between 24 and 72 hours after their stroke begins. Normally, this clot removal procedure is only used in the first few hours after a stroke, but this study explores whether it may still help patients who arrive later. Researchers will compare this treatment to the best available medical management (medications and supportive care) to see if the procedure improves patients' ability to function independently 90 days after treatment.
Most stroke patients who could benefit from clot removal are treated very early—within the first few hours. However, some patients arrive at the hospital after that window has closed, and doctors are uncertain whether clot removal still helps them. This trial exists to answer that question and potentially give hope to patients whose stroke is discovered later than usual.
You likely qualify if…
You likely don't qualify if…
If you enter this trial, you will be randomly assigned to either receive the clot removal procedure or the best medical management (medication and supportive care). You will undergo imaging scans to confirm your clot location and blood flow patterns. Then you will be followed closely for 90 days with clinic visits and assessments to measure how well you're recovering and to watch for any side effects. The main goal is to see how much your ability to function independently improves over those three months.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
China